ClinicalTrials.Veeva

Menu
T

The Center for Clinical Research LLC | Winston-Salem, NC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Relamorelin
Tanezumab
Xyrem®
Hydrocodone Bitartrate
Fentanyl
Sodium Oxybate
morphine sulfate
Suzetrigine
Buprenorphine
Naltrexone Hydrochloride

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 81 total trials

A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM

Prospective, multi-center, double blind, randomized, sham-controlled study to evaluate neuromodulation in patient with chronic migraine. The study hy...

Enrolling
Headache Migraine Chronic
Device: Neurostimulator

This study is a prospective, multicenter (up to 4 sites), randomized, double-blind, two-arm study. Forty-five (45) patients will be randomized to rec...

Enrolling
Knee Osteoarthritis
Device: ACP Max™
Device: Depo-Medrol®

This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and sa...

Active, not recruiting
Post Surgical Neuropathic Pain
Drug: Qutenza (capsaicin) 8% topical system
Drug: capsaicin 0.04% topical system

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabet...

Enrolling
Diabetic Peripheral Neuropathic Pain
Drug: Suzetrigine
Drug: Placebo (matched to Pregabalin)

The purpose of this study is to evaluate the long-term safety and tolerability of SUZ and long-term effectiveness of SUZ in treating pain associated...

Invitation-only
Diabetic Peripheral Neuropathic Pain
Drug: Suzetrigine

Study to evaluate the effectiveness of FAST-SCS (fast-acting paresthesia-free therapy) and additional SCS therapy options in patients with chronic pa...

Active, not recruiting
Chronic Pain
Device: Boston Scientific WaveWriter SCS System

This is a prospective, sham-controlled, randomized, single-blinded, multi-center study comparing two different modes of the NexWave device, transcuta...

Enrolling
Non-Specific Chronic Lower Back Pain
Device: Sham
Device: NexWave

This study is a prospective, randomized study comparing ReActiv8 Therapy to Optimal Medical Management (OMM).

Active, not recruiting
Chronic Low-back Pain
Device: ReActiv8

To evaluate the safety and effectiveness of Spinal Cord Stimulation (SCS) with multiple modalities compared to Conventional Medical Management (CMM)...

Active, not recruiting
Chronic Pain
Other: Conventional Medical Managament
Device: WaveWriter

Trial sponsors

Boston Scientific logo
Pfizer logo
Allergan logo
Jazz Pharmaceuticals logo
Z
B
Medtronic logo
Vertex Pharmaceuticals logo
A
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems